Sign up
Quantellect · Congress · Trade Detail
NYSE: TEVATeva Pharma Industries Ltd ADR
RepublicanHouse

Michael T. McCaul sold Teva Pharma Industries Ltd ADR (NYSE: TEVA)

Michael T. McCaul (R-TX), a U.S. Representative, has disclosed 3 trades in Teva Pharma Industries Ltd ADR (TEVA) since 2015, all sales, worth an estimated $98K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Michael T. McCaul sold $15,001 - $50,000 of Teva Pharma Industries Ltd ADR (NYSE: TEVA) on January 2, 2015. Since that trade, TEVA is down -32.29% against the S&P 500 up +339.12%, an outperformance of -371.40%.

Across these filings, Michael T. McCaul has been a net seller of TEVA. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

TEVA trades
3
Disclosed Vol
$98K
Buys
0
0%
Sells
3
100%
Buy / Sell
0.00
ratio
First → Last
2015

Michael T. McCaul's TEVA trades vs the price

TEVA is down -32.29% since Michael T. McCaul sold on January 2, 2015, versus +339.12% for the S&P 500.

Performance since this trade

Price change since trade
-32.29%
S&P 500 change since trade
+339.12%
Outperformance vs S&P 500
-371.40%

All Michael T. McCaul TEVA trades

TradedTypeSizeReturnEst. profit
January 2, 2015SELL$51.70-32.29%
January 2, 2015SELL$51.70-32.29%
January 2, 2015SELL$51.70-32.29%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Michael T. McCaul & TEVA trading FAQ

Is it legal for Michael T. McCaul to trade Teva Pharma Industries Ltd ADR (TEVA) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Teva Pharma Industries Ltd ADR (TEVA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Michael T. McCaul sell TEVA?

Michael T. McCaul disclosed a sale of $15,001 - $50,000 of Teva Pharma Industries Ltd ADR (TEVA) on January 2, 2015, according to public STOCK Act filings.

How has TEVA performed since Michael T. McCaul's trade?

Since Michael T. McCaul sold TEVA on January 2, 2015, the stock is down -32.29%, versus +339.12% for the S&P 500 over the same period, an outperformance of -371.40%.

How many times has Michael T. McCaul traded TEVA?

Michael T. McCaul has disclosed 3 TEVA trades since 2015. Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional TEVA trades?

Quantellect tracks every disclosed congressional trade in Teva Pharma Industries Ltd ADR (TEVA) on the Teva Pharma Industries Ltd ADR congressional trading page, which aggregates filings across all members of Congress.

Michael T. McCaul's TEVA tradesAll congressional filings for Teva Pharma Industries Ltd ADRMichael T. McCaul's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.